Tom Van Agtmael

2.4k total citations
32 papers, 1.3k citations indexed

About

Tom Van Agtmael is a scholar working on Immunology and Allergy, Genetics and Genetics. According to data from OpenAlex, Tom Van Agtmael has authored 32 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Immunology and Allergy, 8 papers in Genetics and 8 papers in Genetics. Recurrent topics in Tom Van Agtmael's work include Cell Adhesion Molecules Research (17 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (8 papers) and Connective tissue disorders research (5 papers). Tom Van Agtmael is often cited by papers focused on Cell Adhesion Molecules Research (17 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (8 papers) and Connective tissue disorders research (5 papers). Tom Van Agtmael collaborates with scholars based in United Kingdom, Belgium and United States. Tom Van Agtmael's co-authors include Leena Bruckner‐Tuderman, Sonia Alamowitch, Emmanuelle Plaisier, B. Marro, Pierre Ronco, David G. Brownstein, Ursula Schlötzer‐Schrehardt, Karl E. Kadler, John J. Mullins and Yinhui Lu and has published in prestigious journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Tom Van Agtmael

31 papers receiving 1.3k citations

Peers

Countries citing papers authored by Tom Van Agtmael

Since Specialization

Citations

This map shows the geographic impact of Tom Van Agtmael's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tom Van Agtmael with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tom Van Agtmael more than expected).

Fields of papers citing papers by Tom Van Agtmael

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tom Van Agtmael. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tom Van Agtmael. The network helps show where Tom Van Agtmael may publish in the future.

Co-authorship network of co-authors of Tom Van Agtmael

This figure shows the co-authorship network connecting the top 25 collaborators of Tom Van Agtmael. A scholar is included among the top collaborators of Tom Van Agtmael based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tom Van Agtmael. Tom Van Agtmael is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Gene editing for collagen disorders: current advances and future perspectives 2025 ·Gene Therapy ·(unknown), H. Scott Wilkinson, (unknown), B.D. Bax, Tom Van Agtmael, (unknown), Arshad Majid	1
2	Biomechanical and compositional basement membrane defects due to a Col4a1 mutation affect cardiac morphology and function 2025 ·Matrix Biology ·Erin Boland, (unknown), (unknown), William Fuller, Joe Swift, Marco Cantini, Matthew Walker, (unknown), Eilidh MacDonald, Christopher M. Loughrey, Manuel Salmerón‐Sánchez, Godfrey L. Smith, Fabio Quondamatteo, Tom Van Agtmael	0
3	The chemical chaperone 4-phenylbutyric acid rescues molecular cell defects of COL3A1 mutations that cause vascular Ehlers Danlos Syndrome 2025 ·Cell Death Discovery ·(unknown), (unknown), (unknown), (unknown), Uwe Hansen, (unknown), (unknown), (unknown), (unknown), Jennifer Cassels, Alison M. Michie, Neil J. Bulleid, Fransiska Malfait, Tom Van Agtmael	3
4	An In Vitro Model of the Blood–Brain Barrier for the Investigation and Isolation of the Key Drivers of Barriergenesis 2024 ·Advanced Healthcare Materials ·(unknown), (unknown), (unknown), Emma Jackson, Aleixandre Rodrigo‐Navarro, Tom Van Agtmael, Marco Cantini, Matthew J. Dalby, Manuel Salmerón‐Sánchez	4
5	Vascular fibrosis and extracellular matrix remodelling in post-COVID 19 conditions 2024 ·SHILAP Revista de lepidopterología ·(unknown), Robert Sykes, (unknown), Kenneth Mangion, (unknown), Matthew M.Y. Lee, Tom Van Agtmael, Colin Berry	2
6	A novel human iPSC model of COL4A1/A2 small vessel disease unveils a key pathogenic role of matrix metalloproteinases 2023 ·Stem Cell Reports ·(unknown), Mary Goodwin-Trotman, Steven Bell, (unknown), (unknown), Catheline Vilain, Marc Abramowicz, Stuart M. Allan, Tao Wang, M. Zameel Cader, Karen Horsburgh, Tom Van Agtmael, Sanjay Sinha, Hugh S. Markus, Alessandra Granata	11
7	Vascular Collagen Type-IV in Hypertension and Cerebral Small Vessel Disease 2022 ·Stroke ·(unknown), (unknown), (unknown), (unknown), Thomas R. Barrick, Leslie Bridges, Dennis W. Dickson, Margaret M. Esiri, Chad W. Farris, Delyth Graham, Wen-Lang Lin, Daniel N. Meijles, Anthony Pereira, Gregory Perry, Douglas L. Rosene, Anan Shtaya, Tom Van Agtmael, Giovanna Zamboni, Atticus H. Hainsworth	15
8	Identification of an Altered Matrix Signature in Kidney Aging and Disease 2021 ·Journal of the American Society of Nephrology ·Michael J. Randles, Franziska Lausecker, (unknown), Hani Suleiman, (unknown), Maria Kolatsi‐Joannou, Bernard Davenport, (unknown), Sara Falcone, Paul Potter, Tom Van Agtmael, Jill T. Norman, David A. Long, Martin J. Humphries, Jeffrey H. Miner, Rachel Lennon	51
9	The role of basement membranes in cardiac biology and disease 2021 ·Bioscience Reports ·Erin Boland, Fabio Quondamatteo, Tom Van Agtmael	24
10	Biochemical‐ and Biophysical‐Induced Barriergenesis in the Blood–Brain Barrier: A Review of Barriergenic Factors for Use in In Vitro Models 2021 ·SHILAP Revista de lepidopterología ·(unknown), Aleixandre Rodrigo‐Navarro, Matthew J. Dalby, Tom Van Agtmael, Manuel Salmerón‐Sánchez	3
11	Global proteomic analysis of extracellular matrix in mouse and human brain highlights relevance to cerebrovascular disease 2021 ·Journal of Cerebral Blood Flow & Metabolism ·Alexandra Pokhilko, (unknown), Lahiru Handunnetthi, Raphael Heilig, Rachel Lennon, Colin Smith, Stuart M. Allan, Alessandra Granata, Sanjay Sinha, Tao Wang, Hugh S. Markus, Alexandra Naba, Roman Fischer, Tom Van Agtmael, Karen Horsburgh, M. Zameel Cader	19
12	Basement membrane collagens and disease mechanisms 2019 ·Essays in Biochemistry ·(unknown), Yuan Yan Sin, (unknown), Tom Van Agtmael	76
13	4-Sodium phenyl butyric acid has both efficacy and counter-indicative effects in the treatment of Col4a1 disease 2018 ·Human Molecular Genetics ·Frances E. Jones, Lydia Murray, (unknown), Afshan Dean, Alisha Aman, Yinhui Lu, (unknown), (unknown), Karen Horsburgh, William M. Holmes, Karl E. Kadler, Tom Van Agtmael	28
14	The Chemical Chaperone, PBA, Reduces ER Stress and Autophagy and Increases Collagen IV α5 Expression in Cultured Fibroblasts From Men With X-Linked Alport Syndrome and Missense Mutations 2017 ·Kidney International Reports ·(unknown), (unknown), Yanyan Wang, Rachel H. Tan, Lydia Murray, Sharon D. Ricardo, Hayat Dagher, Tom Van Agtmael, Judy Savige	31
15	Chemical chaperone treatment reduces intracellular accumulation of mutant collagen IV and ameliorates the cellular phenotype of a COL4A2 mutation that causes haemorrhagic stroke 2013 ·Human Molecular Genetics ·Lydia Murray, Yinhui Lu, Aislynn Taggart, Nicole Van Regemorter, Catheline Vilain, Marc Abramowicz, Karl E. Kadler, Tom Van Agtmael	50
16	Basement membranes and human disease 2009 ·Cell and Tissue Research ·Tom Van Agtmael, Leena Bruckner‐Tuderman	96
17	COL4A1 Mutations and Hereditary Angiopathy, Nephropathy, Aneurysms, and Muscle Cramps 2007 ·New England Journal of Medicine ·Emmanuelle Plaisier, Olivier Gribouval, Sonia Alamowitch, B. Mougenot, Cathérine Prost, Marie Christine Verpont, B. Marro, Thomas Desmettre, Salomon Y. Cohen, E Roullet, M Dracon, Michel Fardeau, Tom Van Agtmael, Dontscho Kerjaschki, Corinne Antignac, Pierre Ronco	226
18	Dominant mutations of Col4a1 result in basement membrane defects which lead to anterior segment dysgenesis and glomerulopathy 2005 ·Human Molecular Genetics ·Tom Van Agtmael, Ursula Schlötzer‐Schrehardt, Lisa McKie, David G. Brownstein, Angela Lee, Sally H. Cross, Yoshikazu Sado, John J. Mullins, Ernst Pöschl, Ian J. Jackson	116
19	Parametric and nonparametric genome scan analyses for human handedness 2003 ·European Journal of Human Genetics ·Tom Van Agtmael, Susan M. Forrest, Jurgen Del‐Favero, Christine Van Broeckhoven, Robert Williamson	20
20	Genes for left-handedness: How to search for the needle in the haystack? 2001 ·Laterality Asymmetries of Body Brain and Cognition ·Tom Van Agtmael, Susan M. Forrest, Robert Williamson	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact